Incorporation of a doctor to the R&D&i within the "Torres Quevedo" program

2018 Call


No votes yet
 
Related
Madrid – 08 April, 2022 - Moderna and ROVI Pharma Industrial Services, S.A.U. today announced a recall of one lot (lot #000190A) of the...
2 min
08/04/2022
Madrid, 4 de marzo de 2022 - Laboratorios Farmacéuticos Rovi, S.A. was certified carbon neutral in 2021 for the second year running....
3 min
04/03/2022
ROVI REPORTS OPERATING REVENUE GROWTH OF 54% AND NET PROFIT GROWTH OF 151% Operating revenue increased by 54% to 648.7 million euros...
2 min
23/02/2022